Non-Invasive Brain Stimulation for Early Alzheimer's Disease
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
Recruiting
N/A
Interventional Study
Alzheimer s Disease
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Mild Dementia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 55 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Chi-Ying (Roy) Lin · Other
Who this trial is looking for
This trial is looking for people with early Alzheimer's disease to see if a treatment called repetitive transcranial magnetic stimulation (rTMS) can help improve memory. Participants will receive treatment over four weeks and undergo memory tests and brain scans.
Are You a Good Fit for This Trial?
You may be able to join if
- I have early Alzheimer's disease
- I have mild cognitive impairment or mild dementia
- I have a MMSE score between 20 and 28
- I have a CDR-Sum of Boxes score between 0.5 and 8
- I have a positive plasma phosphorylated tau-217 result
You may not be able to join if
- I have another neurological or psychiatric condition
- I have untreated major depressive disorder
- I have a history of seizures
- I have metal in my head or near the TMS coil
- I have heart failure, renal failure, or hepatic failure
- I have substantial alcoholism
- I take medications that could affect my cognition
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if repetitive transcranial magnetic stimulation (rTMS), a non-invasive form of brain stimulation, can improve short-term memory in people with early Alzheimer's disease (AD). The study will also evaluate the safety of this approach.
The main questions it aims to answer are:
* Does rTMS applied to the cerebellum improve short-term memory in people with …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants must meet all of the following inclusion criteria to be eligible for enrollment:
* A clinical diagnosis of early AD, defined as either mild cognitive impairment (MCI) due to AD or mild dementia due to AD;
* Evidence of cognitive impairment, characterized by a MMSE …
Contacts